Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Erik S. Blomain, Amanda M. Pattison & Scott A. Waldman. (2016) GUCY2C ligand replacement to prevent colorectal cancer. Cancer Biology & Therapy 17:7, pages 713-718.
Read now
Read now
Paula Mosińska, Maciej Salaga & Jakub Fichna. (2016) Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review. Expert Opinion on Investigational Drugs 25:3, pages 275-286.
Read now
Read now
Maria Vazquez Roque & Ernest P Bouras. (2015) Epidemiology and management of chronic constipation in elderly patients. Clinical Interventions in Aging 10, pages 919-930.
Read now
Read now
Erik S Blomain, Jieru E Lin, Crystal L Kraft, Urszula T Trela, Justin M Rock, Amanda S Aing, Adam E Snook & Scott A Waldman. (2013) Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis. Expert Review of Clinical Pharmacology 6:5, pages 557-564.
Read now
Read now
J. Fortea & M. Prior. (2013) Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden. Journal of Medical Economics 16:3, pages 329-341.
Read now
Read now
Jeffrey M Johnston & Harvey A Schneier. (2012) Clarification of trial end points presented in a recent review of linaclotide. Expert Review of Gastroenterology & Hepatology 6:1, pages 13-14.
Read now
Read now
Articles from other publishers (17)
Heidi M. Staudacher, Christopher J. Black, Scott B. Teasdale, Antonina Mikocka-Walus & Laurie Keefer. (2023) Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management. Nature Reviews Gastroenterology & Hepatology 20:9, pages 582-596.
Crossref
Crossref
Huiya Zhang & Shiyu Chen. (2022) Cyclic peptide drugs approved in the last two decades (2001–2021). RSC Chemical Biology 3:1, pages 18-31.
Crossref
Crossref
Nayara Braga Emidio, Hue N. T. Tran, Asa Andersson, Philip E. Dawson, Fernando Albericio, Irina Vetter & Markus Muttenthaler. (2021) Improving the Gastrointestinal Stability of Linaclotide. Journal of Medicinal Chemistry 64:12, pages 8384-8390.
Crossref
Crossref
Mulusew Yemiru Tessema, Zewdu Birhanu Wubneh & Assefa Belay Asrie. (2020)
Laxative Activities of 80% Methanolic Extract of the Leaves of
Grewia ferruginea
Hochst Ex A Rich in Mice
. Journal of Evidence-Based Integrative Medicine 25, pages 2515690X2092692.
Crossref
Crossref
Állan S. Pires, William F. Porto, Pryscilla O. Castro, Octavio L. Franco & Sérgio A. Alencar. (2017) Theoretical structural characterization of lymphoguanylin: A potential candidate for the development of drugs to treat gastrointestinal disorders. Journal of Theoretical Biology 419, pages 193-200.
Crossref
Crossref
Andrée-Anne Poirier, Benoit Aubé, Mélissa Côté, Nicolas Morin, Thérèse Di Paolo & Denis Soulet. (2016) Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments. Parkinson's Disease 2016, pages 1-23.
Crossref
Crossref
L. Ashley Blackshaw, Dmitry S. Bordin, Christina Brock, Anne Brokjaer, Asbjørn Mohr Drewes, Adam D. Farmer, Anne Lund Krarup, Christian Lottrup, Antonina A. Masharova, Fouad J. Moawad & Anne Estrup Olesen. (2014) Pharmacologic treatments for esophageal disorders. Annals of the New York Academy of Sciences 1325:1, pages 23-39.
Crossref
Crossref
Christophe Faure. (2014) Lubiprostone in Pediatric Functional Constipation. Journal of Pediatric Gastroenterology & Nutrition 58:3, pages 275-277.
Crossref
Crossref
Corrado Blandizzi & Carmelo Scarpignato. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
633
658
.
J. Fichna, A. Sibaev, M. Sałaga, M. Sobczak & M. Storr. (2013) The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. Neurogastroenterology & Motility 25:8, pages e550-e559.
Crossref
Crossref
Eamonn M.M. Quigley. (2013) Enfermedades del piso pelviano y del esfínter anal: perspectiva de un gastroenterólogo. Revista Médica Clínica Las Condes 24:2, pages 299-304.
Crossref
Crossref
Eamonn M.M. Quigley. (2013) Disorders of the pelvic floor and anal sphincters; a gastroenterologist’s perspective. Revista Médica Clínica Las Condes 24:2, pages 293-298.
Crossref
Crossref
Maria I. Vazquez-Roque & Ernest P. Bouras. (2013) Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome. Advances in Therapy 30:3, pages 203-211.
Crossref
Crossref
Robert W. Busby, Marco M. Kessler, Wilmin P. Bartolini, Alexander P. Bryant, Gerhard Hannig, Carolyn S. Higgins, Robert M. Solinga, Jenny V. Tobin, James D. Wakefield, Caroline B. Kurtz & Mark G. Currie. (2013) Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. Journal of Pharmacology and Experimental Therapeutics 344:1, pages 196-206.
Crossref
Crossref
John Cuppoletti, Anthony T Blikslager, Jayati Chakrabarti, Prashant K Nighot & Danuta H Malinowska. (2012) Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors. BMC Pharmacology 12:1.
Crossref
Crossref
Gregory S Sayuk. (2012) Editorial: Linaclotide: Promising IBS-C Efficacy in an Era of Provisional Study Endpoints. American Journal of Gastroenterology 107:11, pages 1726-1729.
Crossref
Crossref
Lincoln R. Potter. (2011) Guanylyl cyclase structure, function and regulation. Cellular Signalling 23:12, pages 1921-1926.
Crossref
Crossref